1. Home
  2. ORI vs RGEN Comparison

ORI vs RGEN Comparison

Compare ORI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Republic International Corporation

ORI

Old Republic International Corporation

HOLD

Current Price

$40.34

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$116.47

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORI
RGEN
Founded
1923
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.1B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
ORI
RGEN
Price
$40.34
$116.47
Analyst Decision
Buy
Buy
Analyst Count
2
11
Target Price
$42.50
$175.64
AVG Volume (30 Days)
1.4M
865.9K
Earning Date
04-23-2026
04-28-2026
Dividend Yield
9.06%
N/A
EPS Growth
14.81
286.96
EPS
3.72
0.86
Revenue
$9,136,300,000.00
$141,236,000.00
Revenue This Year
$7.07
$14.30
Revenue Next Year
$6.86
$14.52
P/E Ratio
$10.87
$137.02
Revenue Growth
10.99
35.10
52 Week Low
$34.43
$102.97
52 Week High
$46.76
$175.77

Technical Indicators

Market Signals
Indicator
ORI
RGEN
Relative Strength Index (RSI) 51.77 44.35
Support Level $38.75 $112.53
Resistance Level $43.54 $131.81
Average True Range (ATR) 0.84 4.75
MACD 0.17 1.32
Stochastic Oscillator 83.03 62.65

Price Performance

Historical Comparison
ORI
RGEN

About ORI Old Republic International Corporation

Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: